Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

CooTek Cayman Inc / Equity Capital Markets

<p>CooTek, a China-based app developer, plans to raise USD 100 million to list in the US. In this insight, we will discuss the following subjects:</p>
<ul>
<li>Fundamentals of its app business</li>
<li>Drivers that turned the company positive</li>
<li>Concerns on the business</li>
<li>Shareholders</li>
<li>Initial thought on valuation</li>
</ul>

CooTek, a China-based app developer, plans to raise USD 100 million to list in the US. In this insight, we will discuss the following subjects:

Fundamentals of its app business
Drivers that turned the company positive
Concerns on the business
Shareholders
Initial thought on valuation


CooTek (触宝) IPO: A Free App Player Just Turned Profitable